Pathalys Pharma, a newly formed RTP biopharmaceutical company developing therapies for chronic kidney disease, has announced its executive leadership team, led by pharma veteran Neal Fowler.
/PRNewswire/ Pathalys Pharma, Inc., a private, late-stage biopharma company committed to the development and commercialization of a range of best-in-class.